Retatrutide CAS2381089-83-2
  • 21 March 2025 11:35
  • دبي, الإمارات
جديد
EGP100

Retatrutide (RETA; LY3437943) is a novel triple agonist of the GIP, GLP-1 and glucagon receptors under investigation for obesity treatment

Location

دبي,الإمارات

Leave feedback about this

  • Quality
  • Price
  • Service